Certificate Number,Certificate
DK IMP 00136020,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
OGYÉI/43042-6/2020,
sukls169187/2020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_BY_05_GMP_2020_0084,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_NW_04_GMP_2021_0040,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
480213-12928577,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Patientenbezogene Zubereitungen von Zytostatika / Patient individual compounding of cytostatic drugs(en) 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Patientenbezogene Zubereitungen von  monoklonalen Antikörpern / Patient individual compounding of and monoclonal antibodies(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: Patientenbezogene Zubereitungen von  monoklonalen Antikörpern / Patient individual compounding of and monoclonal antibodies(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility
DE_NW_05_GMP_2021_0022,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products
2022_HPF_FR_021,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
2021/HPF/FR/018,
DE_HE_01_GMP_2023_0010,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
ES/064/22,
ES/064/22/1,
ES/155/20,
OGYÉI/311-4/2023,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
OGYÉI/41028-5/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
OGYÉI/41423-5/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
BE/GMP/2020/063,
ES/126HVI/20,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
DE_NW_02_GMP_2020_0027,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification
sukls147805/2020,
UK ManA 20377 Insp GMP/GDP/IMP 20377/13423-0024,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.17  Other: Manufacture and assembly of Investigational medicinal products. CAPSULES, HARD SHELLS INCLUDE PENICI(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: CAPSULES, SOFT SHELLS AND TABLETS INCLUDE PENICILLINS, HORMONES AND CYTOTOXICS/CAPSULES, HARD SHELL(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: Herbal products, Homeopathic products.(en)"
2020/HPF/FR/126,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
480401-12932358,
481159-12940852,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.3  Cell therapy products 1.3.1.6  Human or animal extracted products 1.3.1.7  Tissue engineered products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.6  Human or animal extracted products 1.3.2.7  Tissue engineered products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.4  Biological
DE_HE_01_GMP_2020_0106,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.3  Cell therapy products 1.3.1.4  Gene therapy products 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2021_0016,2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.4  Biological 2.3  Other importation activities 2.3.4  Other: - Allogenic peripheral blood stem cells / stem cell preparations from apheresis - Donor Lymphocytes from apheresis (DLI)(en)
DE_ST_01_GMP_2021_0024,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
LT/07H/2020,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Human plasma for fractionation(en)
OGYÉI/40156-6/2020,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.2  Batch Certification (list of product types) 1.3.2.3  Cell therapy products 1.6  Quality control testing 1.6.4  Biological
OGYÉI/40404-6/2020,
385/2020/CGMP,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.1.16  Veterinary premixes 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.1.16  Veterinary premixes 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.3  Biological medicinal products 2.2.3.2  Immunological products
DE_BY_04_GMP_2024_0029,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: active pharmaceutical ingredients(en)
sukls65515/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.11  Semi-solids 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids 1.5.2  Secondary packaging
ES/159HVI/20,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
ES/159HVI/20b,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
ES/159HVI/20b/1,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
OGYÉI/40098-7/2020,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials(en)
sukls163688/2020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
32201/IMP00074-00002,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products
F059/S1/ME/001/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 7  Other: Cytotoxic IMP(en) 1.1.3  Batch certification
OGYÉI/39038-5/2020,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
OGYÉI/72159-2/2023,
DE_NW_04_GMP_2023_0062,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Primary and secondary packaging (i.e. dividing, packaging and labelling), testing and batch release/batch certification and distribution of non-sterile active pharmaceutical ingredients of microbial, fermentative or animal origin and intermediate products.(en) 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.3  Other importation activities 2.3.4  Other: Batch certification an Batch release of non-sterile active pharmaceutical ingredients (API) of microbial, fermentative or animal origin as well as intermediate products for the production of medicinal products (i.e. mixtures of API and excipients).(en)"
IWSC.405.17.2020.MCI.1 WTC/0062-02-01/117,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: inhalation powder(en)
OGYÉI/19217-2/2022,
OGYÉI/23616-14/2019,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
sukls156442/2020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
480127-12926667,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
480127-13505944,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: Probiotikum / Probiotics(en) 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
480127-13952281,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: Probiotikum / Probiotics(en) 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
BE/GMP/2020/034,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products
BE/GMP/2020/043,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification
BE/GMP/2020/044,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification
DE_HB_01_GMP_2020_0008,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HB_01_GMP_2022_0004,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HE_01_GMP_2020_0115,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HE_01_GMP_2020_0116,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_SN_01_GMP_2020_0033,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.14  Transdermal patches 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DK H 00135620,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Storage of bulk products, and retention and reference samples on behalf of other manufacturers(en) 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Medicinal products for compassionate use (Â§ 29) and vaccines, sera etc. without MA (Â§ 30)(en)"
DK IMP 00135620,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Storage of bulk products and retention samples on behalf of other manufacturers(en)
DK V 00135620,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Storage of bulk products, and retention and reference samples on behalf of other manufacturers(en) 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Medicinal products for compassionate use (Â§ 29) and vaccines, sera etc. without MA (Â§ 30)(en)"
OGYÉI/39024-5/2020,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
OGYÉI/39847-5/2020,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
481721-13287757,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Lagerung / Holding(en) 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation
482358-13304321,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Lagerung / Holding(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation
482358-13661680,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Lagerung / Holding(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation
482390-13230844,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Lagerung von Wirkstoffen, Hilfsstoffen, Bulkware, Packmittel und Fertigwaren im Status ""Frei"", ""Quarantäne"" und ""Gesperrt"" / Holding of active pharmaceutical ingredients, excipients, bulk product, packaging material and finished product in status ""free“, ""quarantine“ and ""blocked“, Lagerung von Wirkstoffen, Hilfsstoffen, Bulkware, Packmittel und Fertigwaren im Status ""Frei"", ""Quarantäne"" und ""Gesperrt"" / Holding of active pharmaceutical ingredients, excipients, bulk product, packaging material and finished product in status ""free“, ""quarantine“ and ""blocked“(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
483904-13208970,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.2.3.7  Tissue engineered products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
483905-13209018,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.2.3.7  Tissue engineered products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
483917-13258458,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
483918-13259821,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
DE_BY_05_GMP_2020_0106,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification
OGYÉI/38931-6/2020,
sukls156423/2020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
ES/119HV/20,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use Special Requirements               : 7  Other: Other(en) 1.2.1.8  Other solid dosage forms Special Requirements               : 7  Other: Other(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use Special Requirements               : 7  Other: Other(en) 1.5.1.8  Other solid dosage forms 1.5.2  Secondary packaging
2021/HPF/FR/168,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: manufacturing of biological investigational medicinal products limited to intermediate products(en) 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.17  Other: suspension [intestinal use](en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.17  Other non-sterile medicinal products: suspension [intestinal use](en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
481089-12939697,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Fischfütterungsarzneimittel/medicated feeds for fish(en)
ES/036HVI/21,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products Special Requirements               : 1  B-lactam Antibiotics 1.3.1.8  Other: [I] Extractos alergenicos liofilizados/ Allergenic liophylised extracts; Productos para diagnóstico de alergias, incluídos penicilánicos/ Allergy diagnostic products incluiding penicilanics(en) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products Special Requirements               : 1  B-lactam Antibiotics 1.3.2.8  Other: [I] Extractos alergenicos liofilizados/ Allergenic liophylised extracts; Productos para diagnóstico de alergias, incluídos penicilánicos/ Allergy diagnostic products incluiding penicilanics(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
480117-12926412,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification
ES/112HV/20,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
ES/112HV/20/1,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
NCF-II/2018/001/CAT´,
NCF-II/2203/001/CAT,
NCF-II/2323/001/CAT,
UP/I-530-10/20-03/09; 381-13-08/241-20-17,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.13  Tablets Special Requirements               : 7  Other: highly potent medicinal products(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.13  Tablets Special Requirements               : 7  Other: highly potent medicinal products(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.8  Other: suspension for injection, solution for injection and suspension for use in drinking water(en) 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
UP/I-530-10/20-03/16; 381-13-08/310-20-09,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
480252-12929143,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical
480252-13131690,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
480252-13673122,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
121/2020/GMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.5  Other: Manufacturing of sterile active substances(en) 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Manufacturing of non-sterile active substances(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Active substances(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
BE/GMP/2020/061,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: storage of reference samples of ATMPs in N2(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.4  Biological
IWSF.405.56.2020.IP.1.1  WTC/0449_01_01/118,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation
IWSF.405.56.2020.IP.2.1  WTC/0449_01_01/119,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging
IWSF.405.56.2020.IP.3.1 WTC/0449_01_01/120,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
IWSF.405.56.2020.IP.4.1 WTC/0449_02_01/121,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
IWSF.405.56.2020.IP.5.1 WTC/0449_03_01/122,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: tablets in-bulk(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
LT/05H/2020,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
NCF/2024/001/CAT,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.5  Solids and implants Special Requirements               : 1  B-lactam Antibiotics 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
OGYÉI/36271-6/2020,
482319-12966927,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility
CG-HU/03V/2021.,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
LT/06H/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Herbal teas(en) 1.6  Quality control testing 1.6.3  Chemical/Physical
NCF-II/2021/001/CAT,
NCF-II/2112/001/CAT,
NCF-II/2116/001/CAT,
R-234/2020/CGMP,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.1.16  Veterinary premixes 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
20MPP033HFR01,
4,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powders(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: powders(en) 1.5.2  Secondary packaging
DK API-H 00135820,
DK H 00134020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DK H 00134320,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
DK IMP 00134320,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
DK V 00134320,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
ES/129HV/20,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
28321/M00199,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.2  Terminally sterilised
387/2020/CGMP,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
BE/GMP/2020/032,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powder, pellets and coated tablets(en) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: powder, pellets and coated tablets(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
NCF/2028/001/CAT,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.5  Gamma irradiation
sukls65932/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.2  Capsules, soft shell 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2020_0098,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
sukls146624/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.4  Other products or manufacturing activity 1.4.3  Other: batch confirmation(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
sukls66162/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
sukls66277/2020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
sukls97753/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.3  Other: storage of non-certified medicinal products(en) 1.6  Quality control testing 1.6.3  Chemical/Physical
66448/28-6-2022,
SK/007V/2021,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
SK/029V/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
1-Jan,
20/03744-11,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification
2022_HPF_FR_077,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.7  Tissue engineered products 1.4  Other products or manufacturing activity 1.4.3  Other: storage limited to lenograstim (non investigational sterile biological medicinal product for clinical trial, with a marketing authorisation)(en)"
480993-12938488,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
480993-13473162,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
482128-12960823,"1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Milchsäurebakterien, sowie Mischungen aus Milchsäurebakterien und Bifidobakterien / Lactic acid bacteria as well as Mixtures of Lactic acid bacteria and Bifidobacteri(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
ES/124HV/20,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
ES/124HV/20/1,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
OGYÉI/31898-5/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.6  Human or animal extracted products 1.3.2  Batch Certification (list of product types) 1.3.2.6  Human or animal extracted products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation
R-183/2020/CGMP,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.16  Veterinary premixes 1.2.1.17  Other: bee-hive strip(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.4.2.4  Chemical 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.1.16  Veterinary premixes 1.5.1.17  Other non-sterile medicinal products: bee-hive strip(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
R-183/2020/GMDP,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.16  Veterinary premixes 1.2.1.17  Other: bee-hive strip(en) 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.4.2.4  Chemical 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.1.16  Veterinary premixes 1.5.1.17  Other non-sterile medicinal products: bee-hive strip(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
sukls111943/2020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
sukls37941/2021,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
sukls66287/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.1.7  Tissue engineered products 1.3.2  Batch Certification (list of product types) 1.3.2.3  Cell therapy products 1.3.2.7  Tissue engineered products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
BE/GMP/2020/051,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
sukls119870/2020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
28431/M12656,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
481071-12939486,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.3  Semi-solids 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.2  Semi-solids 1.1.2.3  Small volume liquids 1.1.2.4  Solids and implants 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Pulver / powder, Pulver / powder(en) 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Herstellung von Zubereitungen monoklonaler Antikörper / Manufacturing of preparations of monoclonal antibodies, Herstellung von Zubereitungen monoklonaler Antikörper / Manufacturing of preparations of monoclonal antibodies(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: Herstellung von Zubereitungen monoklonaler Antikörper / Manufacturing of preparations of monoclonal antibodies, Herstellung von Zubereitungen monoklonaler Antikörper / Manufacturing of preparations of monoclonal antibodies(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: -, -(en) 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
481071-13759148,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.3  Semi-solids 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.2  Semi-solids 1.1.2.3  Small volume liquids 1.1.2.4  Solids and implants 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Pulver / powder, Pulver / powder(en) 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Herstellung von Zubereitungen monoklonaler Antikörper / Manufacturing of preparations of monoclonal antibodies, Herstellung von Zubereitungen monoklonaler Antikörper / Manufacturing of preparations of monoclonal antibodies(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: Herstellung von Zubereitungen monoklonaler Antikörper / Manufacturing of preparations of monoclonal antibodies, Herstellung von Zubereitungen monoklonaler Antikörper / Manufacturing of preparations of monoclonal antibodies(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Pulver / powder, -(en) 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
BE/GMP/2020/033,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.2  Immunological products 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products
BE/GMP/2020/035,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: storage(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
BE/GMP/2020/036,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: storage(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
BE/GMP/2020/037,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: storage(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DK API-H 00135220,
DK H 00135220,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Biological Active Substance(en)
DK IMP 00135220,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Biological Active Substance(en)
sukls56450/2020,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Batch confirmation(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.12  Suppositories 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: dovoz léčivých přípravků k provedení úpravy sekundárního balení, konfirmace šarží(en)"
sukls66822/2020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
CG-HU/11V/2020.,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use Special Requirements               : 6  Ectoparasiticides 1.2.1.17  Other: Collar(en) Special Requirements               : 6  Ectoparasiticides 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use Special Requirements               : 6  Ectoparasiticides 1.5.1.17  Other non-sterile medicinal products: Collar(en) Special Requirements               : 6  Ectoparasiticides 1.5.2  Secondary packaging
DK H 10000101,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products 1.3.2.6  Human or animal extracted products 1.3.2.8  Other: Autovaccines(en) 1.4  Other products or manufacturing activity 1.4.3  Other: Storage of intermediate(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Vaccines, sera etc. without marketing authorisation for delivery in DK only(en)"
DK V 10000102,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products 1.3.2.6  Human or animal extracted products 1.3.2.8  Other: Autovaccines(en) 1.4  Other products or manufacturing activity 1.4.3  Other: Storage of intermediate(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Vaccines, sera etc. without marketing authorisation for delivery in DK only(en)"
OGYÉI/33013-5/2020,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
386/2020/CGMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.2  Immunological products 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
480575-100733480,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.3  Semi-solids 1.1.1.4  Small volume liquids 1.1.1.5  Solids and implants 1.1.1.6  Other: Patientenbezogene Zubereitungen von Zytostatika / Patient individual compounding of cytostatic drugs, Patientenbezogene Zubereitungen von Zytostatika / Patient individual compounding of cytostatic drugs(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.2  Semi-solids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Pulver und Pulvermischungen / Powders and Powder-mixtures, Pulver und Pulvermischungen / Powders and Powder-mixtures(en) 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Patientenbezogene Zubereitungen von monoklonalen Antikörpern / Patient individual compounding of monoclonal antibodies), Patientenbezogene Zubereitungen von monoklonalen Antikörpern / Patient individual compounding of monoclonal antibodies(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: Patientenbezogene Zubereitungen von monoklonalen Antikörpern / Patient individual compounding of monoclonal antibodies, Patientenbezogene Zubereitungen von monoklonalen Antikörpern ( Patient individual compounding of monoclonal antibodies(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Pulver und Pulvermischungen / Powders and Powder-mixtures, Pulver und Pulvermischungen / Powders and Powder-mixtures(en) 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
480575-13121724,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.3  Semi-solids 1.1.1.4  Small volume liquids 1.1.1.5  Solids and implants 1.1.1.6  Other: Patientenbezogene Zubereitungen von Zytostatika / Patient individual compounding of cytostatic drugs, Patientenbezogene Zubereitungen von Zytostatika / Patient individual compounding of cytostatic drugs(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.2  Semi-solids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Pulver und Pulvermischungen / (Powders and Powder-mixtures), Pulver und Pulvermischungen / Powders and Powder-mixtures(en) 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Patientenbezogene Zubereitungen von monoklonalen Antikörpern (Patient individual compounding of monoclonal antibodies), Patientenbezogene Zubereitungen von monoklonalen Antikörpern ( Patient individual compounding of monoclonal antibodies(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: Patientenbezogene Zubereitungen von monoklonalen Antikörpern (Patient individual compounding of monoclonal antibodies), Patientenbezogene Zubereitungen von monoklonalen Antikörpern ( Patient individual compounding of monoclonal antibodies(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Pulver und Pulvermischungen / Powders and Powder-mixtures, Pulver und Pulvermischungen / Powders and Powder-mixtures(en) 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.6  Quality control testing 1.6.3  Chemical/Physical"
480575-13316436,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.3  Semi-solids 1.1.1.4  Small volume liquids 1.1.1.5  Solids and implants 1.1.1.6  Other: Patientenbezogene Zubereitungen von Zytostatika / Patient individual compounding of cytostatic drugs, Patientenbezogene Zubereitungen von Zytostatika / Patient individual compounding of cytostatic drugs(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.2  Semi-solids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Pulver und Pulvermischungen / (Powders and Powder-mixtures), Pulver und Pulvermischungen / Powders and Powder-mixtures(en) 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Patientenbezogene Zubereitungen von monoklonalen Antikörpern (Patient individual compounding of monoclonal antibodies), Patientenbezogene Zubereitungen von monoklonalen Antikörpern ( Patient individual compounding of monoclonal antibodies(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: Patientenbezogene Zubereitungen von monoklonalen Antikörpern ( Patient individual compounding of monoclonal antibodies, Patientenbezogene Zubereitungen von monoklonalen Antikörpern ( Patient individual compounding of monoclonal antibodies(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Pulver und Pulvermischungen / Powders and Powder-mixtures, Pulver und Pulvermischungen / Powders and Powder-mixtures(en) 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
BE/GMP/2020/029,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: drug substances and intermediate bulks(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.8  Other: drug substances and intermediate bulks(en) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.8  Other: drug substances and intermediate bulks(en)
PVD/LV/2020/01V/1,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging
483893-100446691,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
483893-13169091,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
483894-13169882,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
BE/GMP/2020/049,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
BE/GMP/2020/050,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_BB_01_GMP_2020_0022,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification
DE_NW_04_GMP_2021_0010,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Herbal medicinal products homeopathic medicinal products(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation"
DE_SH_01_GMP_2021_0006,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Batch certification only within the scope of importation(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.4  Other: Active Pharmaceutical Ingredients  of microbial origin(en)
OGYÉI/32672-6/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation
sukls111019/2020,2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.3  Other importation activities 2.3.4  Other: Confirmation batches of imported medicinal products(en)
sukls111275/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products
sukls66988/2020,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
483080-101668269,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: eingeschränkt auf homöopathische und pflanzliche Arzneimittel / restricted to herbal and homeopathic medicinal products(en) 1.2.1.17  Other: eingeschränkt auf flüssige homöopathische und pflanzliche Arzneimittel / restricted to liquid herbal and homeopathic medicinal products(en) 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: eingeschränkt auf homöopathische und pflanzliche Arzneimittel / restricted to herbal and homeopathic medicinal products(en) 1.5.1.17  Other non-sterile medicinal products: eingeschränkt auf flüssige homöopathische und pflanzliche Arzneimittel / restricted to liquid herbal and homeopathic medicinal products(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
483080-12981473,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: eingeschränkt auf homöopathische und pflanzliche Arzneimittel / restricted to herbal and homeopathic medicinal products(en) 1.2.1.17  Other: eingeschränkt auf flüssige homöopathische und pflanzliche Arzneimittel / restricted to liquid herbal and homeopathic medicinal products(en) 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: eingeschränkt auf homöopathische und pflanzliche Arzneimittel / restricted to herbal and homeopathic medicinal products(en) 1.5.1.17  Other non-sterile medicinal products: eingeschränkt auf flüssige homöopathische und pflanzliche Arzneimittel / restricted to liquid herbal and homeopathic medicinal products(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
BE/GMP/2020/045,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
OGYÉI/32796-6/2020,
IT-API/112./H/2020,
IT-API/112/H/2020,
IT-API/167/H/2020,
LT/04H/2020,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Human plasma for fractionation(en)
NBF/40/2020/V,
384/2020/CGMP,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
BE/GMP/2020/031,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.2  Batch certification
ES/100HV/20,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids
ES/100HV/20*,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids
sukls101508/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
sukls86107/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: orodispersible films with prolonged release(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: orodispersible films with prolonged release(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
480439-13164935,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification
481218-101166460,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Konfektionierung von Arzneimitteln sowie klinischen Prüfpräparaten in Mehrdosenbehältnisse / Packaging of medicinal products as well as investigational medicinal products into multi-dose containers, -(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation"
481218-12941867,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Konfektionierung von Arzneimitteln sowie klinischen Prüfpräparaten in Mehrdosenbehältnisse / Packaging of medicinal products as well as investigational medicinal products into multi-dose containers, -(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
481218-13840742,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Konfektionierung von Arzneimitteln sowie klinischen Prüfpräparaten in Mehrdosenbehältnisse / Packaging of medicinal products as well as investigational medicinal products into multi-dose containers, -(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation"
483074-13136933,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Lagerung von Ausgangsmaterialien, Zwischenprodukten und Arzneimitteln / Holding of starting materials, intermediates and medicinal products, Lagerung von Ausgangsmaterialien, Zwischenprodukten und Arzneimitteln / Holding of starting materials, intermediates and medicinal products(en)"
483075-13136938,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Lagerung von Ausgangsmaterialien, Zwischenprodukten und Arzneimitteln / Holding of starting materials, intermediates and medicinal products, Lagerung von Ausgangsmaterialien, Zwischenprodukten und Arzneimitteln / Holding of starting materials, intermediates and medicinal products(en)"
DE_NW_03_GMP_2022_0084,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
MT/030HM/2020,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: The company is procuring bulk products from EU/EEA licensed sites and distributing to EU/EEA countries for further processing and distribution.  Part of the bulk may also be sent for processing to third countries.    The company is procuring APIs for further processing with subsequent distribution of the finished product.(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
OGYÉI/16119-8/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products
OGYÉI/30539-5/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use Special Requirements               : 7  Other: Batch certification only(en) 1.2.1.6  Liquids for internal use Special Requirements               : 7  Other: Batch certification only(en) 1.2.1.8  Other solid dosage forms: Granules and powders(en) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: Granules and powders(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
R-166/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.3  Semi-solids 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
R-237/2020/CGMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
sukls104639/2020,
NCF/2038/001/CAT,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
483031-100709130,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Lagerung von Ausgangsmaterial, Zwischenprodukten, Bulkware, Endprodukten und Verpackungsmaterial / Storage of starting materials, excipients, intermediates, bulk, finished product and packaging material, Lagerung von Ausgangsmaterial, Zwischenprodukten, Bulkware, Endprodukten und Verpackungsmaterial / Storage of starting materials, excipients, intermediates, bulk, finished product and packaging material(en)"
DE_SL_01_GMP_2021_0041,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products
NCF-II/2018/001/CAT,
sukls46987/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
119/2020/GMP,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.16  Veterinary premixes 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Active substances /non-sterile/(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
480001-100479371,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
480001-12919802,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
483035-100156257,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.3.1.8  Other: Herstellung von / Manufacture of Albumin intermediate prior to filling, Herstellung von / Manufacture of Albumin intermediate prior to filling(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Herstellung von / Manufacture of Synthetic Aprotinin (concentrated Aprotinin) intermediate prior to filling, Herstellung von / Manufacture of Synthetic Aprotinin (concentrated Aprotinin) intermediate prior to filling(en)"
483035-100479346,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.3.1.8  Other: Herstellung von / Manufacture of Albumin intermediate prior to filling, Herstellung von / Manufacture of Albumin intermediate prior to filling(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Herstellung von / Manufacture of Synthetic Aprotinin (concentrated Aprotinin) intermediate  prior to filling, Herstellung von / Manufacture of Synthetic Aprotinin (concentrated Aprotinin) intermediate  prior to filling(en)"
483035-13060478,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.3.1.8  Other: Manufacture of Albumin intermediate prior to filling(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Manufacture of Synthetic Aprotinin (concentrated Aprotinin) intermediate prior to filling(en)
483035-13784616,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.3.1.8  Other: Herstellung von / Manufacture of Albumin intermediate prior to filling, Herstellung von / Manufacture of Albumin intermediate prior to filling(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Herstellung von / Manufacture of Synthetic Aprotinin (concentrated Aprotinin) intermediate  prior to filling, Herstellung von / Manufacture of Synthetic Aprotinin (concentrated Aprotinin) intermediate  prior to filling(en)"
483035-14266164,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.3.1.8  Other: Herstellung von / Manufacture of Albumin intermediate prior to filling, Herstellung von / Manufacture of Albumin intermediate prior to filling(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Herstellung von / Manufacture of Synthetic Aprotinin (concentrated Aprotinin) intermediate  prior to filling, Herstellung von / Manufacture of Synthetic Aprotinin (concentrated Aprotinin) intermediate  prior to filling(en)"
483036-100499933,
483036-101001483,
483036-13060485,
483036-13061766,
483036-14038085,
483037-100479383,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.4  Biological
483037-101001585,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.4  Biological
483037-13060492,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.4  Biological
483037-13061945,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.4  Biological
483037-14083131,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.4  Biological
483038-100479411,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products
483038-13060496,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products
483039-100479399,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.2  Immunological products 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.3  Other: Central Warehouse / Dispatch(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.3  Other importation activities 2.3.1  Site of physical importation
483039-13060511,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.2  Immunological products 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.3  Other: Central Warehouse / Dispatch(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.3  Other importation activities 2.3.1  Site of physical importation
DE_SL_01_2020_5010_106,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DK API-H 00135720,
383/2020/CGMP,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.16  Veterinary premixes 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.16  Veterinary premixes 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_NW_01_GMP_2021_0020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
sukls64848/2020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
381/2020/CGMP,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
382/2020/CGMP,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_BB_01_GMP_2021_0009,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms Special Requirements               : 7  Other: lyophilisate in vial(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_NW_06_GMP_2021_0006,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.6  Human or animal extracted products
SK/035V/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
sukls58833/2020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
480011-12920826,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.12  Suppositories 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Biological active starting material, Biological active starting material(en)"
480011-13053727,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: biological active starting material, biological active starting material(en)"
480011-13208101,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Biological active starting material, Biological active starting material(en)"
480011-13585826,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Biological active starting material, Biological active starting material(en)"
480011-13637404,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Biological starting material, Biological starting material(en)"
482793-12977712,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Antigens (M. hyopneumoniae)(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Antigens (M. hyopneumoniae)(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
482793-12977725,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Antigens (M. hyopneumoniae)(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Antigens (M. hyopneumoniae)(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
482793-14170487,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Antigens (Mycoplasma hyopneumoniae, Erysipelothrix rhusiopathiae, Salmonella dublin, Salmonella Enteritidis, Salmonella Infantis, Salmonella Typhimurium, Mannheimia haemolytica, Pasteurella (bibersteinia) trehalosi(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Antigens (Mycoplasma hyopneumoniae, Erysipelothrix rhusiopathiae, Salmonella dublin, Salmonella Enteritidis, Salmonella Infantis, Salmonella Typhimurium, Mannheimia haemolytica, Pasteurella (bibersteinia) trehalosi(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
BPFMV/061/004/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.16  Veterinary premixes 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging
OGYÉI/28830-5/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
sukls66981/2020,
DK API-H 10000272,
DK H 00133820,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
DK IMP 00133820,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
2020/HPF/FR/083/Evd,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
R-162/2020/CGMP,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
sukls66852/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
CG-HU/09V/2020.,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
sukls67055/2020,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.1.17  Other: powder(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing"
NBF/30/2020/V,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
OGYÉI/27714-5/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
sukls67071/2020,
480100-100266784,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.2  Homoeopathic products 1.4.1.3  Other: TCM-Granulate, Hydrophile Konzentrate(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Schüßlersalze / Schuessler Salts(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
480100-12925325,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.2  Homoeopathic products 1.4.1.3  Other: TCM-Granulate, Hydrophile Konzentrate(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Schüßlersalze / Schuessler Salts(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
OGYÉI/26356-9/2020,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products Special Requirements               : 7  Other: Fresh frozen plasma by plasmapheresis(en)
482039-102128515,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification
482039-12957444,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification
DK H 00134220,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products Special Requirements               : 5  Radiopharmaceuticals 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products Special Requirements               : 5  Radiopharmaceuticals 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.4  Other: For compassionate use(en)
DK IMP 00134220,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products Special Requirements               : 5  Radiopharmaceuticals 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products Special Requirements               : 5  Radiopharmaceuticals 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
IT/90/H/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Other aseptically prepared products(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.3.2  Batch Certification (list of product types) 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
IT/91/H/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Other aseptically prepared products(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.3.2  Batch Certification (list of product types) 1.3.2.4  Gene therapy products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
sukls336513/2019,
014/2020/API,
015/2021/API,
DE_HB_01_GMP_2020_0009,
INS-482723-12976686,
DK H 00136820,
DK IMP 00134820,
NCF-II/2014/001/CAT,
NCF-II/2015/001/CAT,
NCF-II/2017/001/CAT,
SK/024V/2020,
SK/025V/2020,
480912-12937957,
BE/GMP/2020/019,
BE/GMP/2020/020,
480728-12935546,
480728-13031690,
480728-13207214,
480728-14034473,
483078-13099320,
483079-13031863,
sukls86025/2020,
DE_NW_02_GMP_2020_0016,
DE_NW_02_GMP_2020_0017,
DK H 00133520,
DK V 00133520,
DK H 00133720,
sukls42190/2020,
2021/HPF/FR/043,
480933-12938112,
480933-13932090,
480933-14278779,
5.9.2-2022-084999,
5.9.2-2022-099883,
BE/GMP/2020/039,
BE/GMP/2020/040,
BE/GMP/2020/041,
BE/GMP/2020/042,
SK/021V/2020,
SK/022V/2020,
SK/030V/2020,
SK/031V/2020,
SK/032V/2020,
20/06297-4,
2021/HPF/FR/019,
482968-12980105,
482968-13447655,
CG-HU/07V/2020.,
DE_BB_01_GMP_2020_0014,
DE_BY_04_GMP_2020_0084,
DE_NW_04_GMP_2020_0022,
DE_RP_01_GMP_2020_0041,
ES/056/20,
ES/057/20,
ES/057/20/1,
ES/125/20,
ES/125/20/1,
OGYÉI/10271-4/2020,
OGYÉI/13703-5/2020,
21MPP020HFR01,
482165-13031672,
482433-12970381,
DE_NW_01_GMP_2020_0012,
ES/156I/21,
ES/156I/21/1,
MUN01/2020/001,
NL/V 20/0007,
NL/V 20/0008,
NL/V 20/0009,
OGYÉI/11112-9/2020,
DE_BY_04_GMP_2021_0027,
DE_SN_01_GMP_2020_0017,
OGYÉI/13140-5/2020,
116/2020/GMP,
2020/HPF/FR/119,
20MPP020HFR01,
32039/M12998-00001,
480114-101504800,
480114-12926287,
480114-13451559,
480114-13667242,
DE_BY_04_GMP_2020_0052,
F006/S1/ME/001/2020,
F006/S1/ME/001/2022,
F006/S1/MH/001/2020,
F006/S1/MH/001/2022,
IT-API/170/H/2020,
117/2020/GMP,
2022-HPF-FR-010,
2022/HPF/FR/009,
482100-0016,
482100-13852001,
BE/GMP/2020/026,
BE/GMP/2020/027,
DE_BW_01_GMP_2020_0073,
DE_SN_01_GMP_2020_0013,
ES/064HVI/20,
ES/090HVI/20,
ES/090HVI/20/1,
OGYÉI/2445-7/2021,
BE/GMP/2020/015,
IWSC.405.15.2020.ABU.1 WTC/0164_02_02/112,
IWSF.405.51.2020.KK.1 WTC/0430_01_01/110,
NL/V 20/0006-V1,
OGYÉI/2445-5/2021,
005/2020/RO,
F060/S1/MH/001/2020,
F060/S1/SA/001/2020,
F060/S2/MH/001/2020,
F060/S2/SA/001/2020,
HAD01/2020 /001,
IT-API/101/H/2020,
LT/03H/2020,
NBF/20/2020/V,
20MPP007HFR01,
20MPP007HFR02,
20MPP022HFR01,
20MPP022HFR02,
20MPP022HFR03,
20MPP022HFR04,
20MPP022VFR01,
20MPP022VFR02,
20MPP022VFR03,
20MPP022VFR04,
DE_BY_04_GMP_2021_0035,
DE_NW_04_GMP_2020_0011,
DK API-H 00133320,
OGYÉI/9688-6/2020,
401-5/2020-7,
ES/031/20,
ES/031/20/1,
IT-API/196/H/2020,
482229-12964129,
OGYÉI/9997-5/2020,
sukls15155/2020,
NCF/2016/001/CAT,
2020/HPF/FR/090,
F002/S1/SA/001/2021,
F065/S1/MH/001/2021,
IWSF.405.45.2020.KK.10 WTC/0269_12_01/101,
IWSF.405.45.2020.KK.3 WTC/0269_05_01/94,
IWSF.405.45.2020.KK.6 WTC/0269_08_01/97,
IWSF.405.45.2020.KK.7 WTC/0269_09_01/98,
IWSF.405.55.2020.KK.1 WTC/0105_02_04/116,
SK/015V/2020,
sukls2684/2020,
sukls2687/2020,
2020/HPF/FR/118,
2020/HPF/FR/123,
20MPP017HFR01,
480195-12927917,
DK H 00131020,
DK H 00131120,
DK IMP 00131120,
DK V 00131120,
MED03/2021/001,
MED04/2021/001,
NCF/2308/001/CAT,
NL/H 19/2018507A,
NL/H 19/2018507B,
NL/V 21/0017,
sukls326273/2019,
481769-12946929,
BE/GMP/2020/006,
DE_HE_01_GMP_2021_0017,
NCF/2008/001/CAT,
NCF/2314/001/CAT,
ES/050/20,
ES/050/20/1,
IN-2-14/20/3,
ES/067HV/20,
sukls323168/2019,
004/2020/RO,
2020/HPF/FR/081,
DE_NW_06_GMP_2021_0002,
ES/008HVI/24,
ES/009HVI/24,
ES/063HVI/20,
ES/066HVI/21,
ES/066HVI/21/1,
ES/066HVI/21/1b,
F026/S1/MH/001/2022,
IT-API/78/H/2020,
IWSC.405.14.2020.ABU.1 WTC/0120_01_03/88,
IWSC.405.14.2020.ABU.1 WTC/0120_02_02/89,
IWSF.405.42.2020.KK.1 WTC/0279_16_01/76,
IWSF.405.42.2020.KK.10 WTC/0279_15_01/85,
IWSF.405.42.2020.KK.5 WTC/0279_11_01/80,
IWSF.405.42.2020.KK.6 WTC/0279_13_01/81,
IWSF.405.42.2020.KK.7 WTC/0279_12_01/82,
IWSF.405.42.2020.KK.8 WTC/0279_14_01/83,
IWSF.405.42.2020.KK.9 WTC/0279_10_01/84,
IWSF.405.44.2020.KK.1 WTC/0120_01_01/90,
IWSF.405.44.2020.KK.2 WTC/0120_02_01/91,
sukls2798/2020,
20/00878-22,
2020/HPF/FR/105,
2020/HPF/FR/106,
F051/S1/ME/003/2021,
F051/S1/MH/003/2021,
IT-API/82/H/2020,
IT-API/91/H/2021,
NL/H 20/2012284,
OGYÉI/10818-2/2021,
OGYÉI/4714-6/2020,
OGYÉI/5706-6/2020,
2020/HPF/FR/127,
2020/HPF/FR/128,
20MPP021HVFR01,
20MPP021HVFR02,
ES/079/20,
MU(ES)/NCF/03/2020,
MU(ES)/NCF/10/22,
OGYÉI/10829-2/2021,
OGYÉI/5705-6/2020,
sukls9679/2020,
20/07912-2,
sukls2778/2020,
sukls5771/2020,
sukls5773/2020,
480334-12930618,
NCF/2013/001/CAT,
NCF/2303/001/CAT,
ES/131HVI/20,
F045/S1/MH/001/2022,
OGYÉI/5135-5/2020,
DE_RP_01_GMP_2021_0011,
sukls5597/2020,
20/01233-6,
379/2020/CGMP,
M.C. ANALYSIS-01/2020,
M.C. ANALYSIS-01/2022,
IT/247/H/2022,
DE_NW_02_GMP_2020_0009,
2020/HPF/FR/082 ND-,
2020/HPF/FR/116,
2020/HPF/FR/117,
BG/GMP/2020/171,
CY.ML.0005V,
DE_BE_01_GMP_2021_0007,
DE_BE_01_GMP_2021_0008,
IT/22/H/2023,
NBF/17/2020/V,
SK/009V/2020,
SK/010V/2020,
sukls327743/2019,
20MPP004HFR01,
480166-0098,
480166-0103,
480166-0105,
480166-0109,
480166-100311461,
480166-12927554,
480166-13190765,
480166-14086011,
482146-0021,
DK IMP 10000060,
IWSF.405.53.2020.KK.1 WTC/0243_01_01/113,
NBF/15/2020/V,
NBF/8/2021/V,
UK ManA 20377 Insp GMP/GDP 20377/13423-0019,
ZVA/LV/2020/006A,
sukls327984/2019,
19/20571-12,
20/259784,
20MPP003HFR01,
480166-13386040,
480166-13667335,
480166-13698523,
DE_BE_01_GMP_2021_0031,
DK H 00130320,
DK H 00132320,
DK IMP 00130320,
ES/142HV/20,
IWSF.405.38.2020.KK.1 WTC/0042_01_01/71,
sukls329836/2019,
CG-HU/06V/2020.,
DE_NI_01_GMP_2020_0012,
ES/010HVI/24,
ES/010HVI/24/1,
ES/029HVI/20,
ES/029HVI/20/1,
480204-0028,
480204-101510853,
480204-14160749,
sukls328411/2019,
2020/HPF/FR/121,
2020/HPF/FR/122,
22-314016,
373/2020/CGMP,
IT-API/161/H/2020,
IT-API/90/H/2023,
IT-API/94/H/2020,
IT-API/95/H/2020,
IT/123/H/2020,
IT/65/H/2020,
OGYÉI/2343-5/2020,
2020/HPF/FR/085,
2020/HPF/FR/086,
2020/HPF/FR/093,
2020/HPF/FR/097,
482583-12974115,
DE_NW_03_GMP_2020_0076,
DK H 00133120,
DK IMP 00133120,
ES/018I/20,
ES/018I/20/1,
ES/045HV/20,
ES/045HV/20/1,
ES/046HVI/20,
ES/046HVI/20/1,
IT/56/H/2020,
VOG01/2020/001,
2020/HPF/FR/072,
480334-12930609,
480334-13194745,
480334-14265111,
BE/GMP/2020/002,
DE_NW_01_GMP_2020_0010,
SK/011V/2020,
SK/012V/2020,
sukls244450/2019,
sukls9553/2020,
BPFMV/059/002/2020,
sukls327706/2019,
sukls46790/2020,
BE/GMP/2020/003,
BE/GMP/2020/007,
BE/GMP/2020/013,
NCF-II/2005/001/CAT,
20MPP013HFR01,
20MPP013HFR02,
20MPP013VFR01,
20MPP013VFR02,
IT/231/H/2022,
IT/54/H/2020,
IT/57/H/2020,
IWSF.405.35.2020.KK.4 WTC/0271_03_01/67,
LT/02H/2020,
20MPP005HFR01,
20MPP011HFR01,
5.9.1-2019-096672,
BE/GMP/2020/018,
ES/028HV/20,
ES/028HV/20/1,
ES/039I/20,
ES/044/21,
ES/044/21/1,
IT/25/H/2021,
MU(ES)/NCF/02/2020,
MU(ES)/NCF/16/2022,
NL/API 20/2016374,
NL/H 20/2016374,
SK/013V/2020,
sukls257471/2019,
2020/HPF/FR/095,
2020/HPF/FR/096,
480744-0009,
CG-HU/05V/2020.,
DE_NW_01_GMP_2020_0009,
sukls322402/2019,
sukls322547/2019,
480845-0022,
482231-0008,
OGYÉI/213-5/2020,
2020/HPF/FR/094,
2021/HPF/FR/023,
2021/HPF/FR/024,
481820-0010,
481820-100563086,
481820-13186276,
GMP-030-13.02.2020,
19799/12-2-2020,
30936/M12148,
DE_BY_04_GMP_2023_0081,
OGYÉI/77178-6/2019,
480090-0010,
481921-0157,
481921-0158,
481921-0160,
481921-0161,
481921-0162,
481921-0166,
481921-13305637,
481921-13361548,
2020/HPF/FR/039,
2020/HPF/FR/107,
22-318886,
ES/010HVI/20,
ES/010HVI/20/1,
ES/010HVI/20/2,
IT-API/46/H/2020,
IT/77/H/2020,
114/2020/GMP,
ES/024HVI/20,
002/2020/RO,
BE/GMP/2019/112,
ES/011HVI/20,
MEDIL 01/2020,
UK API 31890 Insp GMP 31890/383321-0015 [H],
UK API 31890 Insp GMP 31890/383321-0015 [V],
113/2020/GMP,
26172/IMP11566-1,
26172/IMP11566-2,
26172/IMP11566-3,
26172/V11583-1,
26172/V11583-2,
26172/V11583-3,
31884/M767-1,
31884/M767-2,
31884/M767-3,
482998-0001,
DK H 00130020,
DK H 00130120,
DK IMP 00130120,
DK V 00130020,
DK V 00130120,
F019/S1/ME/001/2020,
F019/S1/MH/001/2020,
F068/S1/ME/001/2020,
IT-API/247/H/2020,
IT-API/42/H/2020,
IT-API/90/H/2020,
MED07/2020/001,
115/2020/GMP,
2020/HPF/FR/100,
2020/HPF/FR/101,
ES/025/20,
IT-API/225/H/2022,
IT/39/H/2022,
LT/01H/2020,
ZVA/LV/2020/004H,
sukls292065/2019,
1-Feb,
370/2019/CGMP,
BE/GMP/2019/096,
NBF/34/2020/V,
NCF-II/2007/001/CAT,
NCF/2007/001/CAT,
372/2020/CGMP,
BG/GMP/2020/173,
sukls291850/2019,
112/2020/GMP,
BE/GMP/2019/101,
BE/GMP/2019/102,
IT-API/241/H/2020,
IT-API/89/H/2020,
19MPP099HFR01,
19MPP101HFR01,
19MPP101HFR02,
19MPP101VFR01,
19MPP101VFR02,
2021/HPF/FR/025,
DE_BE_01_GMP_2019_0048,
DK API-H 00132620,
DK H 00132620,
DK IMP 00130620,
DK IMP 00132620,
IN-2-14/19/6,
IWSC.405.7.2020.ABU.1 WTC/0384_01_02/26,
IWSF.405.21.2020.KK.3 WTC/0021_01_01/38,
NCF/1957/001/CAT´,
NCF/2269/001/CAT,
UP/I-530-10/19-03/29; 381-10-05/241-20-10,
UP/I-530-10/19-03/29;381-10-05/241-20-10,
UP/I-530-10/20-03/10 381-10-05/241-20-03,
DE_BY_04_GMP_2024_0033,
sukls257826/2019,
sukls312551/2019,
BE/GMP/2019/109,
DE_NW_01_GMP_2020_0008,
F052/S1/ME/001/2021,
F052/S1/MH/001/2021,
OGYÉI/67969-6/2019,
DK H 00130420,
DK V 00130420,
F010/S1/ME/001/2022,
F010/S1/MH/001/2022,
2576-E/01-20/C.VAL.,
374/2020/CGMP,
CG-HU/03V/2020.,
DE_BW_01_GMP_2020_0079,
DE_NI_03_GMP_2022_0001,
DE_NI_03_GMP_2022_0003,
ES/015/20,
IT-API/20/H/2021,
IT-API/50/H/2020,
IT/34/H/2020,
IWSF.405.19.2020.KK.1 WTC/0305_01_02/34,
19MPP052HVFR01,
2020/HPF/FR/057,
2020/HPF/FR/058,
483015-0001,
DK H 00128920,
DK H 00133220,
DK IMP 00133220,
R-349/2019/CGMP,
480790-0022,
DE_HE_01_GMP_2020_0016,
ES/098HV/20,
NBF/9/2020/V,
sukls275438/2019,
DE_BY_05_GMP_2023_0064,
IN-2-14/20/2,
NCF/20009/001/CAT,
19MPP104HFR01,
19MPP104VFR01,
2020/HPF/FR/062,
BE/GMP/2019/110,
BE/GMP/2019/111,
CG-HU/04V/2020.,
IT-API/107/H/2021,
IT-API/54/H/2021,
IT-API/58/H/2020,
IT/148/H/2023,
IT/38/H/2020,
IT/56/H/2021,
NBF/25/2020/V,
060/2019/RO,
19/16628-14,
2020//19-MEDBIO-019,
4279-E/01-20/C.VAL.,
481363-0000,
483065-0000,
BE/GMP/2019/107,
DE_BY_04_GMP_2022_0086,
IWSC.405.6.2020.ABU.1.1 WTC/0033_04_02/25,
sukls275412/2019,
21/292299,
481363-13583378,
DK H 00129020,
DK V 00129020,
IWSF.405.17.2020.KK.1 WTC/0575_01_01/30,
IWSF.405.17.2020.KK.2 WTC/0575_01_01/31,
20/255824,
481327-0052,
481327-12943488,
481363-0046,
BE/GMP/2019/106,
NCF/2002/001/CAT,
ZVA/LV/2021/006H,
OGYÉI/2445-4/2021,
UK MIA 20782 Insp GMP/GDP/IMP 20782/15328-0016,
UK MIA(IMP) 20782 Insp GMP/GDP/IMP 20782/15328-0017,
19MPP096HFR01,
19MPP096HFR02,
2020/HPF/FR/080,
2020/HPF/FR/112,
2020/HPF/FR/113,
2021/HPF/FR/169,
2021/HPF/FR/170,
21/292441,
26163,
480253-0038,
480253-13161979,
480253-14334805,
IT/102/H/2020,
19MPP088HFR01,
DE_BY_05_GMP_2020_0038,
DE_BY_05_GMP_2021_0077,
DE_BY_05_GMP_2021_0078,
DE_NI_01_GMP_2020_0004,
DE_NW_03_GMP_2021_0004,
IWSF.405.14.2020.KK.1 WTC/0327_01_01/27,
sukls257157/2019,
DE_BY_04_GMP_2021_0038,
DK H 00126820,
DK IMP 00126820,
MED06/2020/01,
MED12/2020/01,
MT/0025HM/2022,
MT/0042HM/2022,
MT/012HM/2021,
MT/019HM/2020,
MT/027HM/2020,
MT/031HM/2020,
sukls249729/2019,
BPFMV/058/001/2020,
DE_BY_04_GMP_2020_0050,
IT/117/H/2022,
DE_BY_04_GMP_2020_0030,
480485-0000,
480485-0057,
480485-0061,
483066-0000,
IT-API/66/H/2020,
OGYÉI/65295-5/2019,
sukls267149/2019,
19MPP100HFR01,
19MPP100VFR01,
CG-HU/09V/2021.,
CG-HU/24V/2019.,
DE_BY_05_GMP_2020_0027,
DE_RP_01_GMP_2020_0015,
DE_RP_01_GMP_2020_0016,
DE_RP_01_GMP_2020_0018,
DE_RP_01_GMP_2020_0019,
DK API-H 00128820,
DK H 00128820,
NBF/2/2021/V,
482876-0003,
DE_SN_01_GMP_2020_0003,
SK/006V/2020,
NBF/12/2020/8V,
sukls245726/2019,
109/2019/GMP,
NCF/2262/001/CAT,
DK H 00127920,
DK IMP 00127920,
DK V 00127920,
IN-2-14/19/8 (V),
2020/HPF/FR/068/NT,
2020/HPF/FR/069/NT,
BPFMV/057/008/2019,
IT/118/H/2020,
"UP/I-530-10/19-03/28, 381-10-05/322-20-09",
"UP/I-530-10/19-03/28, 381-10-05/322-20-10",
sukls256494/2019,
2020/HPF/FR/029,
2020/HPF/FR/029-ND,
2021/HPF/FR/030,
6.2.1-2019-076854,
CG-HU/02V/2020.,
DE_HB_01_GMP_2020_0007,
